Skip to content
Open access

681. Transcranial magnetic stimulation reveals altered GABAergic and glutamatergic activity in treatment-resistant schizophrenia

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i249 - i249 · 0 citations

TL;DR

TRS is characterized by the most severe impairments in GABA-A receptor-mediated inhibition and the highest levels of cortical hyperexcitability and inhibitory deficits, alongside shared plasticity impairments across schizophrenia subtypes.

Abstract

Abstract Background Treatment-resistant schizophrenia (TRS), affecting roughly one-third of patients, shows poor response to standard antipsychotics and may reflect more severe or distinct neurophysiological disruptions compared to treatment-responsive cases. Prior evidence from imaging and other methods suggested cortical hyperexcitability and plasticity deficits in schizophrenia, but in vivo functional assessments via non-invasive brain stimulation like transcranial magnetic stimulation (TMS) had not fully clarified differences between TRS, non-TRS schizophrenia, and healthy individuals, especially linking these to clinical and cognitive features. Aims & Objectives The primary goal was to evaluate GABA-mediated cortical inhibition and glutamate-related facilitation in TRS patients compared to non-TRS schizophrenia patients and healthy controls, using TMS paradigms. A secondary objective was to assess LTP-like plasticity across groups. Neurophysiological findings were integrated with measures of clinical symptom severity, cognitive performance, and cortical excitability to explore whether TRS shows a distinctive cortical dysfunction profile, consistent with a continuum of impairment within schizophrenia. Method This cross-sectional study recruited participants, including individuals with TRS, non-TRS schizophrenia patients, and matched healthy controls. Neurophysiological assessments employed TMS over the motor cortex, measuring parameters like active motor threshold, short-interval intracortical inhibition (SICI; primarily mediated by GABA-A receptors), intracortical facilitation (ICF; glutamate-related), and an excitation index (EI) reflecting the balance of inhibition and facilitation. Intermittent theta burst stimulation (iTBS) was used to probe cortical plasticity. Clinical evaluations included neurological soft signs, as well as the Positive and Negative Syndrome Scale (PANSS) and the PANSS Autism Severity Score (PANSS-ASS) for symptoms, alongside cognitive testing. Thus, we analyzed group differences and associations between TMS measures and symptom/cognitive domains. Results TRS patients showed significantly elevated active motor thresholds and markedly impaired SICI compared to healthy controls, consistent with reduced GABAergic inhibition. The EI was higher in TRS subjects compared to non-TRS, supporting greater cortical hyperexcitability in TRS. Cortical plasticity (post-iTBS response) was reduced in TRS and non-TRS relative to controls, without a significant difference between TRS and non-TRS. Deficits in SICI correlated positively with more severe negative symptoms (via PANSS negative subscale) and autistic-like features in the patient groups. Overall, the findings suggest a gradient of neurophysiological abnormalities in schizophrenia, with TRS displaying the most prominent hyperexcitability and inhibitory deficits, alongside shared plasticity impairments across schizophrenia subtypes. Discussion & Conclusions We interpret these findings as evidence of a graded, progressive disruption in cortical physiology across schizophrenia. Specifically, TRS is characterized by the most severe impairments in GABA-A receptor-mediated inhibition (evident from reduced SICI) and the highest levels of cortical hyperexcitability (reflected in the elevated EI). Non-TRS patients display intermediate abnormalities, positioned between TRS and healthy controls. This pattern suggests a neurophysiological spectrum rather than discrete categories, where the degree of excitatory-inhibitory imbalance may contribute to varying treatment responsiveness. Reduced cortical plasticity (measured via post-iTBS changes) was observed in TRS compared to controls, indicating that plasticity deficits might represent a resistance substrate. Motor cortex measures may serve as accessible proxies for broader cortical dysfunction, given convergent evidence from other regions (e.g., prefrontal areas) in schizophrenia research.

Read PDF

Similar papers

Sep 2026

Neurophysiological Signatures of Negative Symptom Improvement After High-Definition Transcranial Direct Current Stimulation: A Transcranial Magnetic Stimulation-Electroencephalography Study.

Left DLPFC-targeted HD-tDCS improves negative symptoms in schizophrenia, potentially by restoring cortical inhibitory function, with exploratory evidence suggesting possible involvement of prefrontal-limbic network plasticity.

Meng Chen, De-Yang Li, Rong Zhu et al. · 0 citations
Open access Sep 2026

Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.

It is indicated that SNT induces progressive, site-specific cortical modulation and selective downstream effects on estimated sgACC source activity, which motivates prospective investigation of subcortical source activity as a potential predictor of treatment response in larger trials.

D. Momi, D. Buchanan, M. Wada et al. · 0 citations
Open access Sep 2026

Toward precision neuromodulation in ADHD: rTMS-evoked excitability as a biomarker and ccPAS as an alternative protocol

Preliminary support is provided for the potential utility of rTMS-evoked excitability as a biomarker for personalized ADHD treatment and for the need for further investigation into cortico-cortical Paired Associative Stimulation as an alternative stimulation approach.

U. Alyagon, L. Bokovza, H. Shalev et al. · 0 citations
Open access Sep 2026

557. ECT-induced effects on brain structure, brain connectivity and cerebrospinal-fluid-based markers – a preliminary analysis

Abstract Background Electroconvulsive therapy (ECT) is among the most effective treatments for severe and treatment-resistant depression. Despite more than 90 years of clinical use, its underlying neurobiological mechanisms remain incompletely understood. One prominent hypothesis suggests that ECT induces neuroplastic...

P. Baldinger-Melich, S. Riessland, B. Spurny-Dworak et al. · 0 citations
Review Open access Sep 2026

675. Beyond the cortex: expanding non invasive brain stimulation for psychiatry

Abstract Background Non-invasive brain stimulation (NIBS) has emerged as a valuable therapeutic approach in psychiatry, offering an alternative to conventional pharmacological treatments. Evidence indicates that NIBS can be highly effective in certain conditions; for instance, repetitive transcranial magnetic stimulati...

G. Kranz · 0 citations
Open access Sep 2026

598. Spectral TMS: a novel protocol for rapid antidepressant response

Abstract Background Accelerated Transcranial Magnetic Stimulation (a-TMS) provides relief of symptoms in patients with Major Depressive Disorder (MDD) as rapidly as one week. A number of individuals, however, have incomplete response to a-TMS treatment, and more than half of those who initially respond may suffer relap...

A. Leuchter, T. Valles, J. Corlier · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.